Precision medicine in COPD: review of mepolizumab for eosinophilic COPD

Mepolizumab can reduce exacerbation rates in those with frequently exacerbating, severe COPD and raised blood eosinophils; this represents a further advance in precision medicine for COPD and targeted therapies http://ow.ly/uklu30m4YcU

Detalles Bibliográficos
Autores principales: Long, Gabriella, Wall, Jasmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269176/
https://www.ncbi.nlm.nih.gov/pubmed/30519304
http://dx.doi.org/10.1183/20734735.026318
_version_ 1783376448223969280
author Long, Gabriella
Wall, Jasmine
author_facet Long, Gabriella
Wall, Jasmine
author_sort Long, Gabriella
collection PubMed
description Mepolizumab can reduce exacerbation rates in those with frequently exacerbating, severe COPD and raised blood eosinophils; this represents a further advance in precision medicine for COPD and targeted therapies http://ow.ly/uklu30m4YcU
format Online
Article
Text
id pubmed-6269176
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-62691762018-12-06 Precision medicine in COPD: review of mepolizumab for eosinophilic COPD Long, Gabriella Wall, Jasmine Breathe (Sheff) Expert Opinion Mepolizumab can reduce exacerbation rates in those with frequently exacerbating, severe COPD and raised blood eosinophils; this represents a further advance in precision medicine for COPD and targeted therapies http://ow.ly/uklu30m4YcU European Respiratory Society 2018-12 /pmc/articles/PMC6269176/ /pubmed/30519304 http://dx.doi.org/10.1183/20734735.026318 Text en Copyright ©ERS 2018 http://creativecommons.org/licenses/by-nc/4.0/ Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Expert Opinion
Long, Gabriella
Wall, Jasmine
Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
title Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
title_full Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
title_fullStr Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
title_full_unstemmed Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
title_short Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
title_sort precision medicine in copd: review of mepolizumab for eosinophilic copd
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269176/
https://www.ncbi.nlm.nih.gov/pubmed/30519304
http://dx.doi.org/10.1183/20734735.026318
work_keys_str_mv AT longgabriella precisionmedicineincopdreviewofmepolizumabforeosinophiliccopd
AT walljasmine precisionmedicineincopdreviewofmepolizumabforeosinophiliccopd

Ejemplares similares